IPO Trending
CTLLABSME / BSEListed
Clinitech Laboratory

Clinitech Laboratory Limited, established in 1990, runs 8 diagnostic centers across Thane and Navi Mumbai, offering a wide range of healthcare and diagnostic tests. The company conducts over 3 lakh tests annually in its NABL-accredited labs (National Accreditation Board for Testing and Calibration Laboratories), equipped with advanced technology and high-end equipment. Its Airoli, Navi Mumbai facility holds an ISO 15189:2012 accreditation certificate for quality testing services. As of December 31, 2023, Clinitech has a team of 74 employees dedicated to delivering accurate and reliable healthcare services.

DRHP
₹96 - ₹9634.43x sub
Listed Price₹115.00
Listing Gain+19.79%

Subscription Status

34.43xTotal Demand
Updated 20 Oct 2026, 01:30 AM
QIBOpen
Awaiting BidsOffered: 2,85,600 sh
Nib22.37x
Hot Bidding (High Profits)Offered: 2,85,600 sh
RetailOpen
Awaiting BidsOffered: 0 sh
CategoryOfferedAppliedTimes
QIB2,85,60000x
Nib2,85,60063,90,00022.37x
Retail01,32,75,6000x

Segment Subscription Demand

Segment / CategoryDemand (Shares)Offered (Shares)Times Sub.
QIB02.74Open
Retail127.450Open
Bidding status cross-verified with live IPO subscription numbers ↗BSE & NSE Bidding Portal Feed

About Clinitech Laboratory IPO Subscription Demand

Live subscription status and bidding analysis for Clinitech Laboratory (CTLLAB) IPO. The issue is subscribed 34.43x overall across Qualified Institutional Buyers (QIB), Non-Institutional Investors (NII/HNI), and Retail Individual Investors (RII). Check real-time grey market demand on our GMP Tracker or review full issue details, lot size, and price band on the IPO Details Page.

Frequently Asked Questions